Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,9.339118966297773e-54,139.28838951310863,17007.862163294834,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.8110748088556294e-51,0,0,70
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,2.0866949349283754e-24,18.874201183431953,1029.1433907410524,"['COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'SLC25A5']",3.140475877067205e-22,0,0,43
3,Nonalcoholic fatty liver disease WP4396,1.624333889595058e-17,10.992538510911425,424.9588838175281,"['NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",1.629748335893708e-15,0,0,37
4,Oxidative phosphorylation WP623,7.437964141925444e-12,13.526411657559198,346.60650671874447,"['ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFA11', 'NDUFB10', 'NDUFA5', 'NDUFB5', 'NDUFA4', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'ATP5MF', 'ATP5ME']",5.597068016798897e-10,0,0,22
5,Mitochondrial CIV Assembly WP4922,7.100928447832746e-11,29.29788281634663,684.639092274752,"['COX8A', 'COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",4.2747589255953135e-09,0,0,16
6,Mitochondrial complex I assembly model OXPHOS system WP4324,2.168599569546633e-10,18.694970414201183,415.9961692950497,"['NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'TMEM186', 'NDUFS6', 'NDUFS5']",1.0879141173892275e-08,0,0,17
7,Mitochondrial complex III assembly WP4921,3.560569966031227e-07,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",1.5310450853934275e-05,0,0,8
8,Pyrimidine metabolism WP4022,8.867670513570993e-05,5.447870778267254,50.83143090825685,"['NT5C', 'POLE4', 'POLD4', 'ZNRD1', 'POLE3', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2J', 'POLR2K', 'NME1', 'POLR2L']",0.0033364610307310863,0,0,12
9,Cellular Proteostasis WP4918,0.0026364769801589666,21.602322206095792,128.2813233569711,"['VBP1', 'PFDN4', 'PFDN5', 'PFDN6']",0.08817550789198321,0,0,4
10,Proteasome Degradation WP183,0.0033287323487730443,6.492576419213973,37.041211459012345,"['PSMB6', 'PSMC5', 'PSMD7', 'H2AFZ', 'PSMB10', 'PSMB9']",0.10019484369806864,0,0,6
11,Microglia Pathogen Phagocytosis Pathway WP3937,0.0077840057307087835,3.251754385964912,15.789492387324163,"['C1QA', 'HCK', 'ITGAM', 'TYROBP', 'NCF4', 'ITGB2', 'CYBB', 'CYBA', 'C1QC']",0.21299870226757672,0,0,9
12,Macrophage markers WP4146,0.014166553531552944,7.196903725205612,30.636294196010958,"['CD74', 'CD163', 'CD14', 'CD68']",0.355344384416453,0,0,4
13,mRNA Processing WP411,0.019036263855319122,4.500968992248062,17.830181302411816,"['LSM7', 'SNRPD1', 'SNRPE', 'SRSF9', 'LSM2']",0.4407627246500812,0,0,5
14,DNA Repair Pathways Full Network WP4946,0.020593051166925065,3.6031052886948083,13.990142915368047,"['POLE4', 'POLD4', 'DCLRE1C', 'CENPX', 'APEX1', 'POLE3']",0.4427506000888889,0,0,6
15,Base Excision Repair WP4752,0.024855805448012757,5.39622641509434,19.937243116011125,"['POLE4', 'POLD4', 'APEX1', 'POLE3']",0.49877316265678934,0,0,4
16,DNA Mismatch Repair WP531,0.053187932823782126,5.389855072463768,15.813423725226563,"['POLE4', 'POLD4', 'POLE3']",0.9994727763237565,0,0,3
17,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.06611733020278102,10.769898697539798,29.254538455061258,"['ELOB', 'ELOC']",0.9994727763237565,0,0,2
18,Ferroptosis WP4313,0.0723331223835463,2.697674418604651,7.085369375222859,"['MAP1LC3A', 'GPX4', 'FTH1', 'CYBB', 'FTL']",0.9994727763237565,0,0,5
19,Selenium Micronutrient Network WP15,0.07359611784453197,1.9457894736842105,5.076881903087006,"['SELENOM', 'PRDX5', 'GPX4', 'ALOX5', 'ALOX5AP', 'SELENOW', 'TXN', 'F2', 'SELENOH']",0.9994727763237565,0,0,9
20,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.07954782127672493,3.081069873522704,7.799410765563306,"['ITGAM', 'TYROBP', 'ITGB2', 'CD14']",0.9994727763237565,0,0,4
21,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.08245399982472308,4.041304347826087,10.085134484071855,"['ZAP70', 'HLA-DRA', 'HLA-DRB1']",0.9994727763237565,0,0,3
22,Ciliary landscape WP4352,0.09943065345413113,1.800682261208577,4.156505550437163,"['PSMD7', 'NDUFA5', 'SSNA1', 'COPS7A', 'MYL6B', 'MCM5', 'COX6C', 'DCAF11', 'LSM4']",0.9994727763237565,0,0,9
23,Eukaryotic Transcription Initiation WP405,0.11701294129585411,3.232173913043478,6.934534560047753,"['POLR2I', 'POLR2J', 'POLR2K']",0.9994727763237565,0,0,3
24,Nanomaterial induced apoptosis WP2507,0.11701294129585411,3.232173913043478,6.934534560047753,"['ENDOG', 'BAX', 'CYCS']",0.9994727763237565,0,0,3
25,Nucleotide Excision Repair WP4753,0.11701294129585411,3.232173913043478,6.934534560047753,"['POLE4', 'POLD4', 'POLE3']",0.9994727763237565,0,0,3
26,Dual hijack model of Vif in HIV infection WP3300,0.11862990532848693,5.383502170767004,11.47626283273633,"['ELOB', 'ELOC']",0.9994727763237565,0,0,2
27,Iron metabolism in placenta WP2007,0.11862990532848693,5.383502170767004,11.47626283273633,"['HEPHL1', 'FTH1']",0.9994727763237565,0,0,2
28,Modulators of TCR signaling and T cell activation WP5072,0.13910940014265663,2.0734570661896243,4.089882874742661,"['ZAP70', 'NDUFB10', 'RHOH', 'ELOB', 'RNF7']",0.9994727763237565,0,0,5
29,Autosomal recessive Osteopetrosis pathways WP4788,0.15696463576993414,inf,inf,['TCIRG1'],0.9994727763237565,0,0,1
30,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.15696463576993414,inf,inf,['MAP1LC3A'],0.9994727763237565,0,0,1
31,Mitochondrial CII Assembly WP4920,0.15696463576993414,inf,inf,['SDHAF1'],0.9994727763237565,0,0,1
32,Non-homologous end joining WP438,0.15696463576993414,inf,inf,['DCLRE1C'],0.9994727763237565,0,0,1
33,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.177678305383113,3.58803666184274,6.199340268844468,"['MAP1LC3A', 'FTL']",0.9994727763237565,0,0,2
34,Allograft Rejection WP2328,0.18754013217819365,1.7021374396690416,2.848973677113718,"['C1QA', 'HLA-DRA', 'HLA-DOA', 'HLA-DRB1', 'HLA-DPA1', 'C1QC']",0.9994727763237565,0,0,6
35,TYROBP causal network in microglia WP3945,0.2148143711120176,1.4872388623206645,2.287345133483227,"['ITGAM', 'TYROBP', 'ITGB2', 'CAPG', 'CYTL1', 'TCIRG1', 'SLC1A5', 'C1QC']",0.9994727763237565,0,0,8
36,Acute viral myocarditis WP4298,0.2244118511246388,1.6833212209302326,2.5153402627250196,"['ENDOG', 'ITGB2', 'CYCS', 'BAX', 'AIF1']",0.9994727763237565,0,0,5
37,Serotonin and anxiety WP3947,0.23992350075459307,2.6903039073806077,3.840234370473141,"['POMC', 'CRH']",0.9994727763237565,0,0,2
38,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.23992350075459307,2.6903039073806077,3.840234370473141,"['H2AFZ', 'HIST1H3E']",0.9994727763237565,0,0,2
39,"GPCRs, Class B Secretin-like WP334",0.23992350075459307,2.6903039073806077,3.840234370473141,"['ADGRE1', 'ADGRE2']",0.9994727763237565,0,0,2
40,Histone Modifications WP2369,0.23992350075459307,2.6903039073806077,3.840234370473141,"['SET', 'HIST1H3E']",0.9994727763237565,0,0,2
41,Copper homeostasis WP3286,0.24244704315040655,2.018478260869565,2.8601271201567986,"['SCO2', 'COX17', 'ATOX1']",0.9994727763237565,0,0,3
42,Metabolism of alpha-linolenic acid WP4586,0.2893214022535667,5.377167630057803,6.668855192156966,['ALOX5'],0.9994727763237565,0,0,1
43,Nanoparticle triggered autophagic cell death WP2509,0.2893214022535667,5.377167630057803,6.668855192156966,['MAP1LC3A'],0.9994727763237565,0,0,1
44,Nanoparticle triggered regulated necrosis WP2513,0.2893214022535667,5.377167630057803,6.668855192156966,['FTL'],0.9994727763237565,0,0,1
45,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.2893214022535667,5.377167630057803,6.668855192156966,['BAX'],0.9994727763237565,0,0,1
46,p38 MAPK Signaling Pathway WP400,0.3029112970940242,2.1516642547033284,2.56976546497024,"['DDIT3', 'HRAS']",0.9994727763237565,0,0,2
47,Androgen receptor signaling pathway WP138,0.3094989139182159,1.5376321791416132,1.8033360899095594,"['SUMO1', 'BAG1', 'STUB1', 'PARK7']",0.9994727763237565,0,0,4
48,TNF-alpha signaling pathway WP231,0.354395827536665,1.345203488372093,1.3954345080392068,"['BAX', 'CYBA', 'TXN', 'HRAS', 'NOX1']",0.9994727763237565,0,0,5
49,Vitamin D Receptor Pathway WP2877,0.35929259962173615,1.1963559459899138,1.2246116981362116,"['LRRC25', 'COLEC11', 'ITGAM', 'ALOX5', 'S100A6', 'DACT2', 'TNFRSF11B', 'CD14', 'HLA-DRB1', 'NOX1']",0.9994727763237565,0,0,10
50,Type II interferon signaling (IFNG) WP619,0.3648774019949029,1.7925711529184756,1.8072592421160363,"['CYBB', 'PSMB9']",0.9994727763237565,0,0,2
51,MET in type 1 papillary renal cell carcinoma WP4205,0.3648774019949029,1.7925711529184756,1.8072592421160363,"['RPL11', 'HRAS']",0.9994727763237565,0,0,2
52,Oxidative Stress WP408,0.3648774019949029,1.7925711529184756,1.8072592421160363,"['CYBB', 'NOX1']",0.9994727763237565,0,0,2
53,Parkinson's disease pathway WP2371,0.3648774019949029,1.7925711529184756,1.8072592421160363,"['CYCS', 'PARK7']",0.9994727763237565,0,0,2
54,Regulation of Microtubule Cytoskeleton WP2038,0.3648774019949029,1.7925711529184756,1.8072592421160363,"['PARD6A', 'F2RL2']",0.9994727763237565,0,0,2
55,Oxidative Damage WP3941,0.3807591816978949,1.466798418972332,1.4163232051382741,"['C1QA', 'CYCS', 'C1QC']",0.9994727763237565,0,0,3
56,Serotonin and anxiety-related events WP3944,0.4009233947260946,2.6878612716763004,2.4566646304465256,['CRH'],0.9994727763237565,0,0,1
57,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.4009233947260946,2.6878612716763004,2.4566646304465256,['COX8A'],0.9994727763237565,0,0,1
58,"COVID-19, thrombosis and anticoagulation WP4927",0.4009233947260946,2.6878612716763004,2.4566646304465256,['F2'],0.9994727763237565,0,0,1
59,Homologous recombination WP186,0.4009233947260946,2.6878612716763004,2.4566646304465256,['POLD4'],0.9994727763237565,0,0,1
60,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.4009233947260946,2.6878612716763004,2.4566646304465256,['HRAS'],0.9994727763237565,0,0,1
61,MTHFR deficiency WP4288,0.4009233947260946,2.6878612716763004,2.4566646304465256,['CYCS'],0.9994727763237565,0,0,1
62,Nanoparticle-mediated activation of receptor signaling WP2643,0.4009233947260946,2.6878612716763004,2.4566646304465256,['HRAS'],0.9994727763237565,0,0,1
63,Peroxiredoxin 2 induced ovarian failure WP4873,0.4009233947260946,2.6878612716763004,2.4566646304465256,['BAX'],0.9994727763237565,0,0,1
64,Purine metabolism and related disorders WP4224,0.4009233947260946,2.6878612716763004,2.4566646304465256,['APRT'],0.9994727763237565,0,0,1
65,Purine metabolism WP4792,0.4009233947260946,2.6878612716763004,2.4566646304465256,['APRT'],0.9994727763237565,0,0,1
66,RalA downstream regulated genes WP2290,0.4009233947260946,2.6878612716763004,2.4566646304465256,['HRAS'],0.9994727763237565,0,0,1
67,CAMKK2  Pathway WP4874,0.42459176426239437,1.5360760802150093,1.3158444384690933,"['FIS1', 'MAP1LC3A']",0.9994727763237565,0,0,2
68,TP53 network WP1742,0.42459176426239437,1.5360760802150093,1.3158444384690933,"['SUMO1', 'BAX']",0.9994727763237565,0,0,2
69,Complement Activation WP545,0.42459176426239437,1.5360760802150093,1.3158444384690933,"['C1QA', 'C1QC']",0.9994727763237565,0,0,2
70,Cytokines and Inflammatory Response WP530,0.42459176426239437,1.5360760802150093,1.3158444384690933,"['HLA-DRA', 'HLA-DRB1']",0.9994727763237565,0,0,2
71,Eicosanoid Synthesis WP167,0.42459176426239437,1.5360760802150093,1.3158444384690933,"['ALOX5', 'ALOX5AP']",0.9994727763237565,0,0,2
72,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.42459176426239437,1.5360760802150093,1.3158444384690933,"['MAP1LC3A', 'DDIT3']",0.9994727763237565,0,0,2
73,IL1 and megakaryocytes in obesity WP2865,0.42459176426239437,1.5360760802150093,1.3158444384690933,"['TLR1', 'F2']",0.9994727763237565,0,0,2
74,Cytosolic DNA-sensing pathway WP4655,0.42618941142267475,1.3442028985507246,1.1464322130489264,"['RNF125', 'POLR2K', 'POLR2L']",0.9994727763237565,0,0,3
75,VEGFA-VEGFR2 Signaling Pathway WP3888,0.45877982898614783,1.0534889412340542,0.8208626325697521,"['SET', 'SDF2L1', 'SSR4', 'SARS', 'RPL13A', 'CYBB', 'TXN', 'RPL10A', 'RPL7', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'ELOC', 'TMSB10', 'CLIC1', 'HRAS']",0.9994727763237565,0,0,19
76,IL-18 signaling pathway WP4754,0.4737594883168917,1.0590017825311944,0.7911331005121652,"['NRN1', 'IMP3', 'COX17', 'TNFRSF11B', 'NDUFC1', 'BPGM', 'RND2', 'NACA', 'TMSB4X', 'CYCS', 'BAX', 'NOX1', 'ITM2C']",0.9994727763237565,0,0,13
77,Cancer immunotherapy by PD-1 blockade WP4585,0.48123468392314833,1.3437047756874096,0.9827859678820794,"['ZAP70', 'HLA-DRB1']",0.9994727763237565,0,0,2
78,Type 2 papillary renal cell carcinoma WP4241,0.48123468392314833,1.3437047756874096,0.9827859678820794,"['ELOB', 'ELOC']",0.9994727763237565,0,0,2
79,DNA IR-double strand breaks and cellular response via ATM WP3959,0.48123468392314833,1.3437047756874096,0.9827859678820794,"['DCLRE1C', 'BAX']",0.9994727763237565,0,0,2
80,IL-6 signaling pathway WP364,0.48123468392314833,1.3437047756874096,0.9827859678820794,"['HCK', 'VIP']",0.9994727763237565,0,0,2
81,Notch Signaling WP268,0.48123468392314833,1.3437047756874096,0.9827859678820794,"['DTX3L', 'DLL3']",0.9994727763237565,0,0,2
82,Nuclear receptors WP170,0.48123468392314833,1.3437047756874096,0.9827859678820794,"['NR0B1', 'NR2F2']",0.9994727763237565,0,0,2
83,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.4950211728124571,1.7914258188824663,1.2596495630170135,['HRAS'],0.9994727763237565,0,0,1
84,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.4950211728124571,1.7914258188824663,1.2596495630170135,['DLL3'],0.9994727763237565,0,0,1
85,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.4950211728124571,1.7914258188824663,1.2596495630170135,['IDH3B'],0.9994727763237565,0,0,1
86,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.4950211728124571,1.7914258188824663,1.2596495630170135,['SST'],0.9994727763237565,0,0,1
87,Cancer immunotherapy by CTLA4 blockade WP4582,0.4950211728124571,1.7914258188824663,1.2596495630170135,['HLA-DRB1'],0.9994727763237565,0,0,1
88,Type II diabetes mellitus WP1584,0.4950211728124571,1.7914258188824663,1.2596495630170135,['SURF1'],0.9994727763237565,0,0,1
89,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.4950211728124571,1.7914258188824663,1.2596495630170135,['VIP'],0.9994727763237565,0,0,1
90,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.4950211728124571,1.7914258188824663,1.2596495630170135,['MAP1LC3A'],0.9994727763237565,0,0,1
91,Fatty acid transporters WP5061,0.4950211728124571,1.7914258188824663,1.2596495630170135,['FABP6'],0.9994727763237565,0,0,1
92,Gastric acid production WP2596,0.4950211728124571,1.7914258188824663,1.2596495630170135,['VIP'],0.9994727763237565,0,0,1
93,Genes targeted by miRNAs in adipocytes WP1992,0.4950211728124571,1.7914258188824663,1.2596495630170135,['TMSB4X'],0.9994727763237565,0,0,1
94,Glycosylation and related congenital defects WP4521,0.4950211728124571,1.7914258188824663,1.2596495630170135,['DPM3'],0.9994727763237565,0,0,1
95,LTF danger signal response pathway WP4478,0.4950211728124571,1.7914258188824663,1.2596495630170135,['CD14'],0.9994727763237565,0,0,1
96,Methionine De Novo and Salvage Pathway WP3580,0.4950211728124571,1.7914258188824663,1.2596495630170135,['TXN'],0.9994727763237565,0,0,1
97,Nanomaterial-induced inflammasome activation WP3890,0.4950211728124571,1.7914258188824663,1.2596495630170135,['NOX1'],0.9994727763237565,0,0,1
98,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.4950211728124571,1.7914258188824663,1.2596495630170135,['EIF1'],0.9994727763237565,0,0,1
99,Osteoclast Signaling WP12,0.4950211728124571,1.7914258188824663,1.2596495630170135,['TNFRSF11B'],0.9994727763237565,0,0,1
100,Overview of nanoparticle effects WP3287,0.4950211728124571,1.7914258188824663,1.2596495630170135,['BAX'],0.9994727763237565,0,0,1
101,Pyrimidine metabolism and related diseases WP4225,0.4950211728124571,1.7914258188824663,1.2596495630170135,['NT5C'],0.9994727763237565,0,0,1
102,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.4950211728124571,1.7914258188824663,1.2596495630170135,['ANAPC11'],0.9994727763237565,0,0,1
103,Non-small cell lung cancer WP4255,0.5129786963884079,1.151552795031056,0.7686856297420819,"['CYCS', 'BAX', 'HRAS']",0.9994727763237565,0,0,3
104,Translation Factors WP107,0.5342985735215232,1.194082649943721,0.7484515660006856,"['EEF1B2', 'EIF1']",0.9994727763237565,0,0,2
105,DNA Replication WP466,0.5342985735215232,1.194082649943721,0.7484515660006856,"['POLD4', 'MCM5']",0.9994727763237565,0,0,2
106,7q11.23 copy number variation syndrome WP4932,0.5678521915234919,1.0231529476812495,0.5789962372775515,"['ATP5MC2', 'ATP5PO', 'ATP5F1E', 'ATP5MC1']",0.9994727763237565,0,0,4
107,Apoptosis Modulation by HSP70 WP384,0.5743568336114816,1.3432080924855492,0.7448148168349223,['CYCS'],0.9994727763237565,0,0,1
108,Biomarkers for pyrimidine metabolism disorders WP4584,0.5743568336114816,1.3432080924855492,0.7448148168349223,['NT5C'],0.9994727763237565,0,0,1
109,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.5743568336114816,1.3432080924855492,0.7448148168349223,['HIST1H3E'],0.9994727763237565,0,0,1
110,Glutathione metabolism WP100,0.5743568336114816,1.3432080924855492,0.7448148168349223,['GPX4'],0.9994727763237565,0,0,1
111,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.5743568336114816,1.3432080924855492,0.7448148168349223,['BAX'],0.9994727763237565,0,0,1
112,MAPK Cascade WP422,0.5743568336114816,1.3432080924855492,0.7448148168349223,['HRAS'],0.9994727763237565,0,0,1
113,miRNA regulation of p53 pathway in prostate cancer WP3982,0.5743568336114816,1.3432080924855492,0.7448148168349223,['BAX'],0.9994727763237565,0,0,1
114,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5743568336114816,1.3432080924855492,0.7448148168349223,['SCO2'],0.9994727763237565,0,0,1
115,Nucleotide metabolism WP404,0.5743568336114816,1.3432080924855492,0.7448148168349223,['NME2'],0.9994727763237565,0,0,1
116,Osteoblast Signaling WP322,0.5743568336114816,1.3432080924855492,0.7448148168349223,['TNFRSF11B'],0.9994727763237565,0,0,1
117,Male infertility WP4673,0.5922730560029664,1.0070652173913044,0.5274881797949922,"['EPSTI1', 'HLA-DRA', 'PEX10']",0.9994727763237565,0,0,3
118,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.5922730560029664,1.0070652173913044,0.5274881797949922,"['PSMC5', 'PSMD7', 'STUB1']",0.9994727763237565,0,0,3
119,Regulation of Actin Cytoskeleton WP51,0.6083506058457361,0.9587832225913622,0.47651900938272146,"['FGF17', 'TMSB4X', 'BRK1', 'CD14', 'F2']",0.9994727763237565,0,0,5
120,Alzheimer's disease WP2059,0.6286412705538973,0.9475703324808185,0.4398569386515962,"['PSENEN', 'ATP5MD', 'CYCS']",0.9994727763237565,0,0,3
121,Integrin-mediated Cell Adhesion WP185,0.6286412705538973,0.9475703324808185,0.4398569386515962,"['ITGAM', 'ITGB2', 'HRAS']",0.9994727763237565,0,0,3
122,16p11.2 proximal deletion syndrome WP4949,0.6287706587554394,0.97645046704381,0.45306198402930303,"['SPN', 'SEZ6L2']",0.9994727763237565,0,0,2
123,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6287706587554394,0.97645046704381,0.45306198402930303,"['ARHGDIB', 'CYCS']",0.9994727763237565,0,0,2
124,Notch Signaling Pathway Netpath WP61,0.6287706587554394,0.97645046704381,0.45306198402930303,"['PSENEN', 'DLL3']",0.9994727763237565,0,0,2
125,Pathways affected in adenoid cystic carcinoma WP3651,0.6287706587554394,0.97645046704381,0.45306198402930303,"['UHRF1', 'HRAS']",0.9994727763237565,0,0,2
126,Complement and Coagulation Cascades WP558,0.6317516928908327,0.9336782987316211,0.42880002457699457,"['C1QA', 'SERPINA1', 'F2', 'C1QC']",0.9994727763237565,0,0,4
127,NRF2 pathway WP2884,0.6407411137620753,0.9200249532127261,0.4095305071605902,"['SERPINA1', 'FTH1', 'TXN', 'SLC2A5', 'SLC5A3', 'FTL']",0.9994727763237565,0,0,6
128,Selective expression of chemokine receptors during T-cell polarization WP4494,0.6412434417171128,1.074277456647399,0.4773510088050752,['CCR1'],0.9994727763237565,0,0,1
129,BDNF-TrkB Signaling WP3676,0.6412434417171128,1.074277456647399,0.4773510088050752,['HRAS'],0.9994727763237565,0,0,1
130,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.6412434417171128,1.074277456647399,0.4773510088050752,['HSD11B2'],0.9994727763237565,0,0,1
131,Energy Metabolism WP1541,0.6412434417171128,1.074277456647399,0.4773510088050752,['UCP3'],0.9994727763237565,0,0,1
132,ERK Pathway in Huntington's Disease WP3853,0.6412434417171128,1.074277456647399,0.4773510088050752,['HRAS'],0.9994727763237565,0,0,1
133,Farnesoid X receptor pathway WP2879,0.6412434417171128,1.074277456647399,0.4773510088050752,['SLCO2B1'],0.9994727763237565,0,0,1
134,Galanin receptor pathway WP4970,0.6412434417171128,1.074277456647399,0.4773510088050752,['POMC'],0.9994727763237565,0,0,1
135,Gastric Cancer Network 2 WP2363,0.6412434417171128,1.074277456647399,0.4773510088050752,['S100A6'],0.9994727763237565,0,0,1
136,Interleukin-11 Signaling Pathway WP2332,0.6412434417171128,1.074277456647399,0.4773510088050752,['HRAS'],0.9994727763237565,0,0,1
137,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.6412434417171128,1.074277456647399,0.4773510088050752,['BAX'],0.9994727763237565,0,0,1
138,NOTCH1 regulation of endothelial cell calcification WP3413,0.6412434417171128,1.074277456647399,0.4773510088050752,['DLL3'],0.9994727763237565,0,0,1
139,PDGFR-beta pathway WP3972,0.6412434417171128,1.074277456647399,0.4773510088050752,['HRAS'],0.9994727763237565,0,0,1
140,Photodynamic therapy-induced unfolded protein response WP3613,0.6412434417171128,1.074277456647399,0.4773510088050752,['DDIT3'],0.9994727763237565,0,0,1
141,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6412434417171128,1.074277456647399,0.4773510088050752,['HRAS'],0.9994727763237565,0,0,1
142,Sleep regulation WP3591,0.6701058663234416,0.8948383984563435,0.35822132256857964,"['CRH', 'HCRTR1']",0.9994727763237565,0,0,2
143,Synaptic Vesicle Pathway WP2267,0.6701058663234416,0.8948383984563435,0.35822132256857964,"['SLC32A1', 'PARK7']",0.9994727763237565,0,0,2
144,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6701058663234416,0.8948383984563435,0.35822132256857964,"['APEX1', 'HRAS']",0.9994727763237565,0,0,2
145,Senescence and Autophagy in Cancer WP615,0.6892388426496188,0.8585195936139333,0.31951301949407057,"['GABARAPL2', 'MAP1LC3A', 'HRAS', 'GABARAP']",0.9994727763237565,0,0,4
146,Ectoderm Differentiation WP2858,0.6892388426496188,0.8585195936139333,0.31951301949407057,"['TNFRSF11B', 'NR2F2', 'ARHGAP15', 'LY6E']",0.9994727763237565,0,0,4
147,Signaling of Hepatocyte Growth Factor Receptor WP313,0.6976320724750306,0.894990366088632,0.3222533028141987,['HRAS'],0.9994727763237565,0,0,1
148,Small Ligand GPCRs WP247,0.6976320724750306,0.894990366088632,0.3222533028141987,['PTAFR'],0.9994727763237565,0,0,1
149,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.6976320724750306,0.894990366088632,0.3222533028141987,['HRAS'],0.9994727763237565,0,0,1
150,ATM Signaling Network in Development and Disease  WP3878,0.6976320724750306,0.894990366088632,0.3222533028141987,['DCLRE1C'],0.9994727763237565,0,0,1
151,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.6976320724750306,0.894990366088632,0.3222533028141987,['HRAS'],0.9994727763237565,0,0,1
152,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6976320724750306,0.894990366088632,0.3222533028141987,['HRAS'],0.9994727763237565,0,0,1
153,IL17 signaling pathway WP2112,0.6976320724750306,0.894990366088632,0.3222533028141987,['IL17RA'],0.9994727763237565,0,0,1
154,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.6976320724750306,0.894990366088632,0.3222533028141987,['SUPT4H1'],0.9994727763237565,0,0,1
155,Interferon type I signaling pathways WP585,0.6976320724750306,0.894990366088632,0.3222533028141987,['ZAP70'],0.9994727763237565,0,0,1
156,Monoamine Transport WP727,0.6976320724750306,0.894990366088632,0.3222533028141987,['TNFRSF11B'],0.9994727763237565,0,0,1
157,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.6976320724750306,0.894990366088632,0.3222533028141987,['HLA-DRA'],0.9994727763237565,0,0,1
158,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6976320724750306,0.894990366088632,0.3222533028141987,['HRAS'],0.9994727763237565,0,0,1
159,Genotoxicity pathway WP4286,0.7076314344873381,0.8257820327284872,0.28558176407229374,"['RPS27', 'TRIAP1']",0.9994727763237565,0,0,2
160,IL-3 signaling pathway WP286,0.7076314344873381,0.8257820327284872,0.28558176407229374,"['HCK', 'HRAS']",0.9994727763237565,0,0,2
161,Leptin signaling pathway WP2034,0.7076314344873381,0.8257820327284872,0.28558176407229374,"['BAX', 'HRAS']",0.9994727763237565,0,0,2
162,Prolactin Signaling Pathway WP2037,0.7076314344873381,0.8257820327284872,0.28558176407229374,"['ZAP70', 'HRAS']",0.9994727763237565,0,0,2
163,Prostaglandin Synthesis and Regulation WP98,0.7076314344873381,0.8257820327284872,0.28558176407229374,"['HSD11B2', 'S100A6']",0.9994727763237565,0,0,2
164,Chemokine signaling pathway WP3929,0.7400663151596184,0.7944955114766435,0.23915544911036576,"['CCR1', 'HCK', 'GNG10', 'HRAS']",0.9994727763237565,0,0,4
165,G Protein Signaling Pathways WP35,0.7415232297617851,0.7665908621046102,0.22924806960537447,"['GNG10', 'HRAS']",0.9994727763237565,0,0,2
166,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7415232297617851,0.7665908621046102,0.22924806960537447,"['IFI27L2', 'HRAS']",0.9994727763237565,0,0,2
167,7-oxo-C and 7beta-HC pathways WP5064,0.7451683928679057,0.7669281585466556,0.22558812572071513,['HSD11B2'],0.9994727763237565,0,0,1
168,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.7451683928679057,0.7669281585466556,0.22558812572071513,['ZAP70'],0.9994727763237565,0,0,1
169,Transcriptional cascade regulating adipogenesis WP4211,0.7451683928679057,0.7669281585466556,0.22558812572071513,['DDIT3'],0.9994727763237565,0,0,1
170,Cells and molecules involved in local acute inflammatory response  WP4493,0.7451683928679057,0.7669281585466556,0.22558812572071513,['ITGB2'],0.9994727763237565,0,0,1
171,G13 Signaling Pathway WP524,0.7451683928679057,0.7669281585466556,0.22558812572071513,['ARHGDIB'],0.9994727763237565,0,0,1
172,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7451683928679057,0.7669281585466556,0.22558812572071513,['HRAS'],0.9994727763237565,0,0,1
173,One-carbon metabolism and related pathways WP3940,0.7451683928679057,0.7669281585466556,0.22558812572071513,['GPX4'],0.9994727763237565,0,0,1
174,PDGF Pathway WP2526,0.7451683928679057,0.7669281585466556,0.22558812572071513,['HRAS'],0.9994727763237565,0,0,1
175,SARS-CoV-2 mitochondrial interactions WP5038,0.7451683928679057,0.7669281585466556,0.22558812572071513,['NOX1'],0.9994727763237565,0,0,1
176,Ebola Virus Pathway on Host WP4217,0.7630036253162961,0.7659133319510678,0.20717380911767472,"['HLA-DRA', 'HLA-DOA', 'HLA-DRB1', 'HLA-DPA1']",0.9994727763237565,0,0,4
177,T-cell receptor (TCR) signaling pathway WP69,0.7719957915531619,0.7152918475639171,0.1851004921325112,"['ZAP70', 'HRAS']",0.9994727763237565,0,0,2
178,White fat cell differentiation WP4149,0.7719957915531619,0.7152918475639171,0.1851004921325112,"['DDIT3', 'NR2F2']",0.9994727763237565,0,0,2
179,Exercise-induced Circadian Regulation WP410,0.7719957915531619,0.7152918475639171,0.1851004921325112,"['SUMO1', 'UCP3']",0.9994727763237565,0,0,2
180,Melanoma WP4685,0.7719957915531619,0.7152918475639171,0.1851004921325112,"['BAX', 'HRAS']",0.9994727763237565,0,0,2
181,Regulatory circuits of the STAT3 signaling pathway WP4538,0.7719957915531619,0.7152918475639171,0.1851004921325112,"['CSF3R', 'F2RL2']",0.9994727763237565,0,0,2
182,Alpha 6 Beta 4 signaling pathway WP244,0.7852404096343836,0.6708815028901735,0.1621959038871392,['HRAS'],0.9994727763237565,0,0,1
183,Amyotrophic lateral sclerosis (ALS) WP2447,0.7852404096343836,0.6708815028901735,0.1621959038871392,['BAX'],0.9994727763237565,0,0,1
184,Statin inhibition of cholesterol production WP430,0.7852404096343836,0.6708815028901735,0.1621959038871392,['APOC1'],0.9994727763237565,0,0,1
185,Striated Muscle Contraction Pathway WP383,0.7852404096343836,0.6708815028901735,0.1621959038871392,['TPM2'],0.9994727763237565,0,0,1
186,Canonical and non-canonical Notch signaling WP3845,0.7852404096343836,0.6708815028901735,0.1621959038871392,['DLL3'],0.9994727763237565,0,0,1
187,Unfolded protein response WP4925,0.7852404096343836,0.6708815028901735,0.1621959038871392,['DDIT3'],0.9994727763237565,0,0,1
188,GABA receptor Signaling WP4159,0.7852404096343836,0.6708815028901735,0.1621959038871392,['SLC32A1'],0.9994727763237565,0,0,1
189,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7852404096343836,0.6708815028901735,0.1621959038871392,['DDIT3'],0.9994727763237565,0,0,1
190,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.7852404096343836,0.6708815028901735,0.1621959038871392,['RNF125'],0.9994727763237565,0,0,1
191,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.7852404096343836,0.6708815028901735,0.1621959038871392,['RAB13'],0.9994727763237565,0,0,1
192,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7992858934690376,0.6704052098408104,0.1501952925133095,"['CYCS', 'BAX']",0.9994727763237565,0,0,2
193,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7992858934690376,0.6704052098408104,0.1501952925133095,"['BAX', 'HRAS']",0.9994727763237565,0,0,2
194,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.8190187613906604,0.5961785484906872,0.11902602637592112,['TLR1'],0.9994727763237565,0,0,1
195,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8190187613906604,0.5961785484906872,0.11902602637592112,['HCK'],0.9994727763237565,0,0,1
196,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.8190187613906604,0.5961785484906872,0.11902602637592112,['TNFRSF11B'],0.9994727763237565,0,0,1
197,Vitamin D-sensitive calcium signaling in depression WP4698,0.8190187613906604,0.5961785484906872,0.11902602637592112,['GPX4'],0.9994727763237565,0,0,1
198,IL-2 signaling pathway WP49,0.8190187613906604,0.5961785484906872,0.11902602637592112,['HRAS'],0.9994727763237565,0,0,1
199,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.8190187613906604,0.5961785484906872,0.11902602637592112,['BAX'],0.9994727763237565,0,0,1
200,DNA damage response WP707,0.8236403009403144,0.6307993530263046,0.1223885561603598,"['CYCS', 'BAX']",0.9994727763237565,0,0,2
201,Endometrial cancer WP4155,0.8236403009403144,0.6307993530263046,0.1223885561603598,"['BAX', 'HRAS']",0.9994727763237565,0,0,2
202,Folate Metabolism WP176,0.8236403009403144,0.6307993530263046,0.1223885561603598,"['GPX4', 'F2']",0.9994727763237565,0,0,2
203,miRNA regulation of DNA damage response WP1530,0.8236403009403144,0.6307993530263046,0.1223885561603598,"['CYCS', 'BAX']",0.9994727763237565,0,0,2
204,EGF/EGFR signaling pathway WP437,0.8388177823623719,0.6429565217391304,0.11300718299010724,"['NDUFA13', 'NEDD8', 'HRAS']",0.9994727763237565,0,0,3
205,Complement system WP2806,0.8426365580401391,0.6863073941562313,0.1175092385192763,"['FCGR3A', 'RPS19', 'ITGB2', 'VSIG4', 'TXN']",0.9994727763237565,0,0,5
206,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8453068155302488,0.5955941469689661,0.10009294496305744,"['POMC', 'HRAS']",0.9994727763237565,0,0,2
207,Blood Clotting Cascade WP272,0.847490717899423,0.5364161849710982,0.0887636785468416,['F2'],0.9994727763237565,0,0,1
208,Endothelin Pathways WP2197,0.847490717899423,0.5364161849710982,0.0887636785468416,['RIIAD1'],0.9994727763237565,0,0,1
209,Integrated Cancer Pathway WP1971,0.847490717899423,0.5364161849710982,0.0887636785468416,['BAX'],0.9994727763237565,0,0,1
210,Neural Crest Cell Migration during Development WP4564,0.847490717899423,0.5364161849710982,0.0887636785468416,['F2RL2'],0.9994727763237565,0,0,1
211,Neural Crest Cell Migration in Cancer WP4565,0.847490717899423,0.5364161849710982,0.0887636785468416,['F2RL2'],0.9994727763237565,0,0,1
212,NO/cGMP/PKG mediated Neuroprotection WP4008,0.847490717899423,0.5364161849710982,0.0887636785468416,['CYCS'],0.9994727763237565,0,0,1
213,Ovarian infertility WP34,0.847490717899423,0.5364161849710982,0.0887636785468416,['GJA4'],0.9994727763237565,0,0,1
214,RANKL/RANK signaling pathway WP2018,0.847490717899423,0.5364161849710982,0.0887636785468416,['TNFRSF11B'],0.9994727763237565,0,0,1
215,Apoptosis Modulation and Signaling WP1772,0.8689217700117886,0.6297276530350893,0.08847810854288898,"['ENDOG', 'CYCS', 'BAX', 'TNFRSF11B']",0.9994727763237565,0,0,4
216,Cardiac Progenitor Differentiation WP2406,0.8714888677012015,0.48751970572779824,0.06705940213101608,['MESP1'],0.9994727763237565,0,0,1
217,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.8714888677012015,0.48751970572779824,0.06705940213101608,['ALOX5'],0.9994727763237565,0,0,1
218,Inflammatory Response Pathway WP453,0.8714888677012015,0.48751970572779824,0.06705940213101608,['ZAP70'],0.9994727763237565,0,0,1
219,Kit receptor signaling pathway WP304,0.8714888677012015,0.48751970572779824,0.06705940213101608,['HRAS'],0.9994727763237565,0,0,1
220,Metabolic reprogramming in colon cancer WP4290,0.8714888677012015,0.48751970572779824,0.06705940213101608,['SLC1A5'],0.9994727763237565,0,0,1
221,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.8714888677012015,0.48751970572779824,0.06705940213101608,['BAX'],0.9994727763237565,0,0,1
222,Pregnane X receptor pathway WP2876,0.8714888677012015,0.48751970572779824,0.06705940213101608,['PSMC5'],0.9994727763237565,0,0,1
223,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8815361494143743,0.5357452966714906,0.06755173283111483,"['BAX', 'HRAS']",0.9994727763237565,0,0,2
224,Glycolysis and Gluconeogenesis WP534,0.8815361494143743,0.5357452966714906,0.06755173283111483,"['LDHC', 'SLC2A5']",0.9994727763237565,0,0,2
225,Peptide GPCRs WP24,0.8815361494143743,0.5357452966714906,0.06755173283111483,"['CCR1', 'HCRTR1']",0.9994727763237565,0,0,2
226,Ras signaling WP4223,0.8819126342286596,0.6115695625129587,0.07685122685406012,"['ZAP70', 'GNG10', 'RASAL3', 'HRAS']",0.9994727763237565,0,0,4
227,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.8917153235181275,0.4467726396917148,0.051203871207869116,['HRAS'],0.9994727763237565,0,0,1
228,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8917153235181275,0.4467726396917148,0.051203871207869116,['ZAP70'],0.9994727763237565,0,0,1
229,Bladder cancer WP2828,0.8917153235181275,0.4467726396917148,0.051203871207869116,['HRAS'],0.9994727763237565,0,0,1
230,Toll-like Receptor Signaling related to MyD88 WP3858,0.8917153235181275,0.4467726396917148,0.051203871207869116,['TLR1'],0.9994727763237565,0,0,1
231,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8917153235181275,0.4467726396917148,0.051203871207869116,['ITGB2'],0.9994727763237565,0,0,1
232,PPAR signaling pathway WP3942,0.8917153235181275,0.4467726396917148,0.051203871207869116,['FABP6'],0.9994727763237565,0,0,1
233,Apoptosis WP254,0.8965516072531957,0.510095789401144,0.055702165538853245,"['CYCS', 'BAX']",0.9994727763237565,0,0,2
234,Corticotropin-releasing hormone signaling pathway WP2355,0.8965516072531957,0.510095789401144,0.055702165538853245,"['POMC', 'CRH']",0.9994727763237565,0,0,2
235,Aryl Hydrocarbon Receptor Pathway WP2873,0.9087621438784721,0.41229435304579815,0.03944497873313256,['BAX'],0.9994727763237565,0,0,1
236,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.9087621438784721,0.41229435304579815,0.03944497873313256,['NDUFA13'],0.9994727763237565,0,0,1
237,p53 transcriptional gene network WP4963,0.9087621438784721,0.41229435304579815,0.03944497873313256,['BAX'],0.9994727763237565,0,0,1
238,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9087621438784721,0.41229435304579815,0.03944497873313256,['BAX'],0.9994727763237565,0,0,1
239,Toll-like Receptor Signaling Pathway WP75,0.9097797926331711,0.48677805551901066,0.0460261769538747,"['TLR1', 'CD14']",0.9994727763237565,0,0,2
240,ESC Pluripotency Pathways WP3931,0.9097797926331711,0.48677805551901066,0.0460261769538747,"['FGF17', 'HRAS']",0.9994727763237565,0,0,2
241,TGF-beta Signaling Pathway WP366,0.9214109176552325,0.46548795067010634,0.03809980592877801,"['PARD6A', 'SUMO1']",0.9994727763237565,0,0,2
242,DNA damage response (only ATM dependent) WP710,0.9214109176552325,0.46548795067010634,0.03809980592877801,"['BAX', 'HRAS']",0.9994727763237565,0,0,2
243,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.9231285631109454,0.3827415359207267,0.03061425762169488,['RNF7'],0.9994727763237565,0,0,1
244,Aryl Hydrocarbon Receptor Netpath WP2586,0.9231285631109454,0.3827415359207267,0.03061425762169488,['HRAS'],0.9994727763237565,0,0,1
245,MECP2 and Associated Rett Syndrome WP3584,0.9231285631109454,0.3827415359207267,0.03061425762169488,['SST'],0.9994727763237565,0,0,1
246,Oncostatin M Signaling Pathway WP2374,0.9231285631109454,0.3827415359207267,0.03061425762169488,['HRAS'],0.9994727763237565,0,0,1
247,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9293275360712197,0.501358695652174,0.03674660122326394,"['WNT9A', 'HRAS', 'DLL3']",0.9994727763237565,0,0,3
248,Hepatitis B infection WP4666,0.9293275360712197,0.501358695652174,0.03674660122326394,"['CYCS', 'BAX', 'HRAS']",0.9994727763237565,0,0,3
249,Breast cancer pathway WP4262,0.9313600468658316,0.5343976777939042,0.03800066891169025,"['FGF17', 'BAX', 'HRAS', 'DLL3']",0.9994727763237565,0,0,4
250,Glioblastoma signaling pathways WP2261,0.9352355264907954,0.3571290944123314,0.023912250427901977,['HRAS'],0.9994727763237565,0,0,1
251,Head and Neck Squamous Cell Carcinoma WP4674,0.9352355264907954,0.3571290944123314,0.023912250427901977,['HRAS'],0.9994727763237565,0,0,1
252,Pancreatic adenocarcinoma pathway WP4263,0.9352355264907954,0.3571290944123314,0.023912250427901977,['BAX'],0.9994727763237565,0,0,1
253,Hippo-Merlin Signaling Dysregulation WP4541,0.937517764873824,0.486034255599473,0.031358722206143316,"['ITGAM', 'ITGB2', 'HRAS']",0.9994727763237565,0,0,3
254,Small cell lung cancer WP4658,0.9405651036411131,0.42801736613603475,0.02622651169297025,"['CYCS', 'BAX']",0.9994727763237565,0,0,2
255,B Cell Receptor Signaling Pathway WP23,0.9405651036411131,0.42801736613603475,0.02622651169297025,"['PIK3AP1', 'HRAS']",0.9994727763237565,0,0,2
256,Cell cycle WP179,0.9405651036411131,0.42801736613603475,0.02622651169297025,"['MCM5', 'ANAPC11']",0.9994727763237565,0,0,2
257,Ciliopathies WP4803,0.9405651036411131,0.42801736613603475,0.02622651169297025,"['DNAAF3', 'CCDC28B']",0.9994727763237565,0,0,2
258,AGE/RAGE pathway WP2324,0.9454379523467782,0.33471820809248554,0.018780040261108594,['CYCS'],0.9994727763237565,0,0,1
259,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9454379523467782,0.33471820809248554,0.018780040261108594,['HRAS'],0.9994727763237565,0,0,1
260,TGF-beta Receptor Signaling WP560,0.9454379523467782,0.33471820809248554,0.018780040261108594,['HRAS'],0.9994727763237565,0,0,1
261,Thermogenesis WP4321,0.9454379523467782,0.33471820809248554,0.018780040261108594,['HRAS'],0.9994727763237565,0,0,1
262,ErbB signaling pathway WP673,0.9454379523467782,0.33471820809248554,0.018780040261108594,['HRAS'],0.9994727763237565,0,0,1
263,Nuclear Receptors Meta-Pathway WP2882,0.9534407244526096,0.6117365914407364,0.029166390758786284,"['PSMC5', 'SERPINA1', 'FTH1', 'SLCO2B1', 'ALOX5AP', 'BAX', 'TXN', 'SLC2A5', 'SLC5A3', 'FTL']",0.9994727763237565,0,0,10
264,Vitamin B12 metabolism WP1533,0.9540350760509096,0.314943896633798,0.014819634936180787,['F2'],0.9994727763237565,0,0,1
265,Pathogenic Escherichia coli infection WP2272,0.9540350760509096,0.314943896633798,0.014819634936180787,['CD14'],0.9994727763237565,0,0,1
266,Prader-Willi and Angelman Syndrome WP3998,0.9540350760509096,0.314943896633798,0.014819634936180787,['POMC'],0.9994727763237565,0,0,1
267,Pre-implantation embryo WP3527,0.9540350760509096,0.314943896633798,0.014819634936180787,['DDIT3'],0.9994727763237565,0,0,1
268,22q11.2 copy number variation syndrome WP4657,0.9552298807524623,0.3960979793107145,0.018142576608080083,"['RANBP1', 'MRPL40']",0.9994727763237565,0,0,2
269,Regulation of toll-like receptor signaling pathway WP1449,0.9571138055391475,0.44516908212560385,0.01951308548834231,"['TLR1', 'CUEDC2', 'CD14']",0.9994727763237565,0,0,3
270,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.961279175494316,0.29736673089274246,0.011743133232198137,['TMSB4X'],0.9994727763237565,0,0,1
271,G1 to S cell cycle control WP45,0.961279175494316,0.29736673089274246,0.011743133232198137,['MCM5'],0.9994727763237565,0,0,1
272,Circadian rhythm related genes WP3594,0.9612888660009057,0.4743751007901951,0.018728483724573218,"['CRH', 'AVP', 'RPS27A', 'HCRTR1']",0.9994727763237565,0,0,4
273,MAPK Signaling Pathway WP382,0.9612888660009057,0.4743751007901951,0.018728483724573218,"['FGF17', 'DDIT3', 'CD14', 'HRAS']",0.9994727763237565,0,0,4
274,Endoderm differentiation WP2853,0.9663960115455927,0.36858126653026596,0.01259868965621247,"['HHEX', 'NME1']",0.9994727763237565,0,0,2
275,Integrated breast cancer pathway WP1984,0.9663960115455927,0.36858126653026596,0.01259868965621247,"['BAX', 'FAU']",0.9994727763237565,0,0,2
276,Osteoblast differentiation WP4787,0.9663960115455927,0.36858126653026596,0.01259868965621247,"['WNT9A', 'DLL3']",0.9994727763237565,0,0,2
277,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9673829306951798,0.28163979312442955,0.00933941866977189,['TNFRSF11B'],0.9994727763237565,0,0,1
278,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9725256316759122,0.267485549132948,0.0074518390837052815,['CTSV'],0.9994727763237565,0,0,1
279,Endochondral Ossification WP474,0.9725256316759122,0.267485549132948,0.0074518390837052815,['CTSV'],0.9994727763237565,0,0,1
280,Lung fibrosis WP3624,0.9725256316759122,0.267485549132948,0.0074518390837052815,['SERPINA1'],0.9994727763237565,0,0,1
281,Retinoblastoma gene in cancer WP2446,0.9725256316759122,0.267485549132948,0.0074518390837052815,['H2AFZ'],0.9994727763237565,0,0,1
282,Pathways in clear cell renal cell carcinoma WP4018,0.9768584140750329,0.25467932837875035,0.00596294884553984,['LDHC'],0.9994727763237565,0,0,1
283,Insulin Signaling WP481,0.9805086749334715,0.24303730951129796,0.004783894372440256,['HRAS'],0.9994727763237565,0,0,1
284,Hematopoietic Stem Cell Differentiation WP2849,0.9835837967577367,0.23240764011058054,0.003846914025564849,['RHOH'],0.9994727763237565,0,0,1
285,Proximal tubule transport WP4917,0.9835837967577367,0.23240764011058054,0.003846914025564849,['SLC7A9'],0.9994727763237565,0,0,1
286,Adipogenesis WP236,0.9860426119452882,0.3048997312383709,0.004285581692266582,"['GDF10', 'DDIT3']",0.9994727763237565,0,0,2
287,Glucocorticoid Receptor Pathway WP2880,0.9861742878865638,0.22266377649325625,0.003099964605292988,['ALOX5AP'],0.9994727763237565,0,0,1
288,Gastrin signaling pathway WP4659,0.9901945164013873,0.2054246331702979,0.0020242284394071334,['HRAS'],0.9994727763237565,0,0,1
289,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9917427247102488,0.19776279169342753,0.0016397611482872386,['HRAS'],0.9994727763237565,0,0,1
290,Spinal Cord Injury WP2431,0.9923618194995707,0.3259094942324756,0.0024989113074353345,"['APEX1', 'TNFSF13', 'AIF1']",0.9994727763237565,0,0,3
291,"GPCRs, Other WP117",0.9941449629620365,0.18402431732110824,0.001080635871546441,['ADGRE2'],0.9994727763237565,0,0,1
292,Neural Crest Differentiation WP2064,0.9950698904713883,0.17784200385356455,0.0008789489999177347,['DLL3'],0.9994727763237565,0,0,1
293,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9971963634927249,0.35339147286821704,0.000992172731355664,"['FGF17', 'GNG10', 'CSF3R', 'ITGB2', 'HRAS']",0.9994727763237565,0,0,5
294,Myometrial relaxation and contraction pathways WP289,0.997354841006127,0.2312967973321588,0.000612627409847921,"['CRH', 'IGFBP6']",0.9994727763237565,0,0,2
295,Mesodermal commitment pathway WP2857,0.9975222101342804,0.15674940496429784,0.0003888740603837429,['RPL38'],0.9994727763237565,0,0,1
296,"GPCRs, Class A Rhodopsin-like WP455",0.9983136172803998,0.3351302619958787,0.0005656349553153536,"['CCR1', 'GPR65', 'PTAFR', 'F2RL2', 'HCRTR1']",0.9994727763237565,0,0,5
297,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9983340810482324,0.2169585634543253,0.0003617367784141984,"['SST', 'AVP']",0.9994727763237565,0,0,2
298,Focal Adhesion WP306,0.9989537401923877,0.20427474117778024,0.0002138363351028409,"['HCK', 'HRAS']",0.9994727763237565,0,0,2
299,Calcium Regulation in the Cardiac Cell WP536,0.9992566512510928,0.1297405893134076,9.64783677298031e-05,['GJA4'],0.9994727763237565,0,0,1
300,PI3K-Akt signaling pathway WP4172,0.9994036894460158,0.3036454156642609,0.00018112097357218544,"['FGF17', 'GNG10', 'CSF3R', 'PIK3AP1', 'HRAS']",0.9994727763237565,0,0,5
301,Metapathway biotransformation Phase I and II WP702,0.9994727763237565,0.1236389299637048,6.520256085992508e-05,['GPX4'],0.9994727763237565,0,0,1
